High‐Flow Nasal Cannula Versus Noninvasive Ventilation in the Treatment of Hypercapnic Respiratory Failure: Meta‐Analysis of Randomized Controlled Trials
Journal of Evidence-Based Medicine · 2026-06 · 19 (2)
DOI: 10.1111/jebm.70139 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Journal of Evidence-Based Medicine, online erschienen am 25.06.2026. Verfasst von Lan Yang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonary and Critical Care Medicine, State Key Laboratory of Respiratory Health and Multimorbidity, Precision Medicine Key Laboratory …. Hauptthemen laut MEDLINE: Cannula, Hypercapnia, Noninvasive Ventilation, Oxygen Inhalation Therapy. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China, Sichuan Province Science and Technology Support Program, Noncommunicable Chronic Diseases-National Science and Technology Major Project.
Abstract (Originalsprache)
Aim
To evaluate efficacy and safety of high‐flow nasal cannula (HFNC) versus noninvasive ventilation (NIV) in adults with hypercapnic respiratory failure (HRF).
Methods
We conducted a meta‐analysis of randomized controlled trials from PubMed, Embase, The Cochrane Library, Wanfang, CNKI, and Weipu comparing HFNC with NIV in HRF patients. Primary outcomes were mortality and endotracheal intubation. Secondary outcomes included blood gas values, hospital/ intensive care unit (ICU) length of stay, nasal skin breakdown, and comfort. Pooled risk ratios (RR) and mean differences (MD) with 95% confidence intervals (CI) were calculated.
Results
Twenty trials involving 1835 patients were included. No significant differences were observed in mortality (RR, 0.94; 95% CI, 0.69 to 1.28), endotracheal intubation (RR, 0.87; 95% CI, 0.71 to 1.06), PaCO 2 (MD, –0.87 mmHg; 95% CI, –2.98 to 1.25) or PaO 2 (MD, 2.67 mmHg; 95% CI, –0.66 to 6.01). However, HFNC significantly reduced hospital stay (MD, –0.69 days; 95% CI, –1.08 to –0.30) and ICU stay (MD, –0.98 days; 95% CI, –1.50 to –0.45), lowered nasal skin breakdown risk (RR, 0.20; 95% CI, 0.09 to 0.45) and improved comfort (MD, –1.19; 95% CI, –1.98 to –0.41). Subgroup and sensitivity analyses confirmed the principal findings.
Conclusions
HFNC was not significantly different from NIV for mortality and endotracheal intubation in HRF but was associated with shorter hospital and ICU stays, reduced nasal facial skin breakdown and improved comfort. Larger trials in diverse populations are needed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pulmonary and Critical Care Medicine, State Key Laboratory of Respiratory Health and Multimorbidity, Precision Medicine Key Laboratory of Sichuan Province, West China Hospital of Sichuan University, Chengd…
- Institute of Respiratory Health, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, China.
- Center for Evidence-Based Medicine, Affiliated Hospital of Chengdu University, Chengdu, China.
- West China Hospital, Sichuan University, Chengdu, China.
Förderung
- National Natural Science Foundation of China
- Sichuan Province Science and Technology Support Program
- Noncommunicable Chronic Diseases-National Science and Technology Major Project
Zitieren
APA
Yang, L., Fan, S., Cheng, C., Chen, B., Wang, H., Zhang, Y., & Li, W. (2026). High‐Flow Nasal Cannula Versus Noninvasive Ventilation in the Treatment of Hypercapnic Respiratory Failure: Meta‐Analysis of Randomized Controlled Trials. Journal of Evidence-Based Medicine, 19(2). https://doi.org/10.1111/jebm.70139
Vancouver
Yang L, Fan S, Cheng C, Chen B, Wang H, Zhang Y, et al. High‐Flow Nasal Cannula Versus Noninvasive Ventilation in the Treatment of Hypercapnic Respiratory Failure: Meta‐Analysis of Randomized Controlled Trials. Journal of Evidence-Based Medicine. 2026;19(2). doi:10.1111/jebm.70139
BibTeX
@article{Yang2026,
author = {Yang, Lan and Fan, Shijie and Cheng, Chuke and Chen, Bojiang and Wang, Haoyu and Zhang, Yu and Li, Weimin},
title = {High‐Flow Nasal Cannula Versus Noninvasive Ventilation in the Treatment of Hypercapnic Respiratory Failure: Meta‐Analysis of Randomized Controlled Trials},
journal = {Journal of Evidence-Based Medicine},
year = {2026},
volume = {19},
number = {2},
doi = {10.1111/jebm.70139}
}
EUVIMED